×
×
×
×
×

Tell us once and we'll remember.

I'm an...

Don't worry, you can always change this selection using the icons at the top left of the site.
  

The Diabetes and Obesity Market Opportunity

July 6, 2023

 

Health care analysts Marshall Gordon and Brittany Henderson join Jeff Schulze to highlight new treatments for the chronic conditions of diabetes and obesity. They quantify the size of the Type 1 and Type 2 diabetes and obesity markets, discuss innovations in managing diabetes and explain how GLP-1 therapeutics developed to treat diabetes can be effective in addressing the much larger obese population.

Related Perspectives

Holding Steady in a Value-Led Market
International Growth EAFE 3Q25: The Strategy mostly kept pace in a value-driven period with our positioning in IT and financials, which reflects our orientation as growth managers, creating minimal headwinds.
Doubling Down on AI Winners
Large Cap Growth 3Q25: We were quite active in repositioning the portfolio during the quarter, upgrading our exposure to perceived AI winners in infrastructure software.
Leaning on Financials Amid Cyclical Leadership
International Growth ADR 3Q25:We meaningfully repositioned our bank exposure, adding three new positions while closing out of two others, highlighting an energetic period of activity.
Large Cap Growth Monthly Update
Large Cap Growth August 2025: We actively repositioned the Strategy in August to better capture the most attractive growth trends.
Large Cap Growth Monthly Update
Large Cap Growth July 2025: A primary research focus is determining the trajectory of Gen AI and how best to participate in the broad buildout of workloads.
More
  • Past performance is no guarantee of future results. Copyright © 2023 ClearBridge Investments. All opinions and data included in this commentary are as of the publication date and are subject to change. The opinions and views expressed herein are of the author and may differ from other portfolio managers or the firm as a whole, and are not intended to be a forecast of future events, a guarantee of future results or investment advice. This information should not be used as the sole basis to make any investment decision. The statistics have been obtained from sources believed to be reliable, but the accuracy and completeness of this information cannot be guaranteed. Neither ClearBridge Investments, LLC  nor its information providers are responsible for any damages or losses arising from any use of this information.

more